A novel role of Hippo-Yap/TAZ signaling pathway in lymphatic vascular development

키워드

참고문헌 (134)

1. Adams RH, "Molecular regulation of angiogenesis and lymphangiogenesis", Nat Rev Mol Cell Biol, 8, pp.464~478 (2007)
2. Oliver G, "The rediscovery of the lymphatic system : old and new insights into the development and biological function of the lymphatic vasculature", Genes Dev, 16, pp.773~783 (2002)
3. Harvey NL, "Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity", Nat Genet, 37, pp.1072~1081 (2005)
4. Dieterich LC, "Lymphatic vessels : new targets for the treatment of inflammatory diseases", Angiogenesis, 17, pp.359~371 (2014)
5. Lim K-C, "Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning", J Clin Invest, 122, pp.3705~3717 (2012)
6. Martel C, "Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice", J Clin Invest, 123, pp.1571~1579 (2013)
7. Randolph GJ, "Dendriticcell trafficking to lymph nodes through lymphatic vessels", Nat Rev Immunol, 5, pp.617~628 (2005)
8. Da Mesquita S, "Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease", Nature, 560, pp.185~191 (2018)
9. Wiig H, "Immune cells control skin lymphatic electrolyte homeostasis and blood pressure", J Clin Invest, 123, pp.2803~2815 (2013)
10. Ho YC, "Lymphatic vasculature in energy homeostasis and obesity", Front Physiol, 11, pp.3~ (2020)
11. Vaahtomeri K, "Lymphangiogenesis guidance by paracrine and pericellular factors", Genes Dev, 31, pp.1615~1634 (2017)
12. Cha B, "Mechanotransduction activates canonical Wnt", β-catenin signaling to promote lymphatic vascular patterning and the development of lymphatic and lymphovenous valves, 2016, pp.30, 1454~1469
13. Tatin F, "Planar cell polarity protein Celsr1 regulates endothelial adherens junctions and directed cell rearrangements during valve morphogenesis", Dev Cell, 26, pp.31~44 (2013)
14. Sabine A, "Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphaticvalve formation", Dev Cell, 22, pp.430~445 (2012)
15. McLatchie LM, "RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor", Nature, 393, pp.333~339 (1998)
16. Murtomaki A, "Notch1functions as a negative regulator of lymphatic endothelial cell differentiation in the venous endothelium", Development, 140, pp.2365~2376 (2013)
17. Dunworth WP, "Bone morphogenetic protein 2 signaling negatively modulates lymphatic development in vertebrate embryos", Circ Res, 114, pp.56~66 (2014)
18. Bazigou E, "Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis", Dev Cell, 17, pp.175~186 (2009)
19. 김완태, "The history and regulatory mechanism of the Hippo pathway", BMB Reports, 51(3), pp.106~118 (2018), 생화학분자생물학회
20. Misra JR, "The Hippo signaling network and its biological functions", Annu Rev Genet, 52, pp.65~87 (2018)
21. Ma S, "The Hippo pathway : biology and pathophysiology", Annu Rev Biochem, 88, pp.577~604 (2019)
22. Zanconato F, "YAP", TAZ at the roots of cancer, 2016, pp.29, 783~803
23. Totaro A, "YAP", TAZ upstream signals and downstream responses, 2018, pp.20, 888~899
24. Piccolo S, "The biology of YAP", TAZ : hippo signaling and beyond, 2014, pp.94, 1287~1312
25. Meng Z, "Mechanisms of Hippo pathway regulation", Genes Dev, 30, pp.1~17 (2016)
26. Yu FX, "Hippo pathway in organ size control, tissue homeostasis, and cancer", Cell, 163, pp.811~828 (2015)
27. Justice RW, "The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation", Genes Dev, 9, pp.534~546 (1995)
28. Xu T, "Identifying tumor suppressors in genetic mosaics : the Drosophila lats gene encodes a putative protein kinase", Development, 121, pp.1053~1063 (1995)
29. Tapon N, "Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines", Cell, 110, pp.467~478 (2002)
30. Harvey KF, "The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis", Cell, 114, pp.457~467 (2003)
31. Udan RS, "Hippo promotes proliferation arrest and apoptosis in the Salvador", Warts pathway, 2003, pp.5, 914~920
32. Wu S, "Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts", Cell, 114, pp.445~456 (2003)
33. Zheng Y, "The Hippo signaling pathway in development and disease", Dev Cell, 50, pp.264~282 (2019)
34. Yu FX, "The Hippo pathway : regulators and regulations", Genes Dev, 27, pp.355~371 (2013)
35. Zhao B, "A coordinated phosphorylation by Lats and CK1regulates YAP stability through SCF(beta-TRCP)", Genes Dev, 24, pp.72~85 (2010)
36. Zhao B, "Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control", Genes Dev, 21, pp.2747~2761 (2007)
37. Huang W, "The N-terminal phosphodegron targets TAZ", WWTR1 protein for SCFbeta-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition, 2012, pp.287, 26245~26253
38. Zhang L, "The TEAD", TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control, 2008, pp.14, 377~387
39. Wu S, "The TEAD", TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway, 2008, pp.14, 388~398
40. Kim J, "YAP", TAZ regulates sprouting angiogenesis and vascular barrier maturation, 2017, pp.127, 3441~3461
41. Sakabe M, "YAP", TAZ-CDC42signaling regulates vascular tip cell migration, 2017, pp.114, 10918~10923
42. Wang X, "YAP", TAZ orchestrate VEGF signaling during developmental angiogenesis, 2017, pp.42, 462~478
43. Giampietro C, "The actin-binding protein EPS8 binds VE-cadherin and modulates YAP localization and signaling", J Cell Biol, 211, pp.1177~1192 (2015)
44. Cha B, "YAP and TAZ maintain PROX1 expression in the developing lymphatic and lymphovenous valves in response to VEGF-C signaling", Development, 147, pp.dev195453~ (2020)
45. Cho H, "YAP and TAZ negatively regulate Prox1 during developmental and pathologic lymphangiogenesis", Circ Res, 124, pp.225~242 (2019)
46. Sabine A, "FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature", J Clin Invest, 125, pp.3861~3877 (2015)
47. Plouffe SW, "The Hippo pathway effector proteins YAP and TAZ have both distinct and overlapping functions in the cell", J Biol Chem, 293, pp.11230~11240 (2018)
48. Sun C, "Common and distinctive functions of the Hippo effectors Taz and Yap in skeletal muscle stem cell function", Stem Cells, 35, pp.1958~1972 (2017)
49. Escobedo N, "Lymphangiogenesis : origin, specification, and cell fate determination", Annu Rev Cell Dev Biol, 32, pp.677~691 (2016)
50. Bui K, "Ras pathways on Prox1 and lymphangiogenesis : insights for therapeutics", Front Cardiovasc Med, 7, pp.597374~ (2020)
51. Grimm L, "Yap1promotes sprouting and proliferation of lymphatic progenitors downstream of Vegfc in the zebrafish trunk", Elife, 8, pp.e42881~ (2019)
52. Azad T, "A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis", Nat Commun, 9, pp.1061~ (2018)
53. Yeh YW, "Targeting the VEGF-C", VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS, Oncotarget, pp.2017, 8[DOI]
54. Hamaratoglu F, "The tumour-suppressor genes NF2", Merlin and expanded act through Hippo signalling to regulate cell proliferation and apoptosis, 2006, pp.8, 27~36
55. Willecke M, "The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size", Curr Biol, 16, pp.2090~2100 (2006)
56. Kuta A, "Fat4-Dchs1signalling controls cell proliferation in developing vertebrae", Development, 143, pp.2367~2375 (2016)
57. Alders M, "Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome", Hum Genet, 133, pp.1161~1167 (2014)
58. Betterman KL, "Atypical cadherin FAT4 orchestrates lymphatic endothelial cell polarity in response to flow", J Clin Invest, 130, pp.3315~3328 (2020)
59. Cheong SS, "The planar polarity component VANGL2 is a key regulator of mechanosignaling", Front Cell Dev Biol, 8, pp.577201~ (2020)
60. Choi HJ, "Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2", Nat Commun, 6, pp.6943~ (2015)
61. Hägerling R, "Distinct roles of VE-cadherin for development and maintenance of specific lymph vessel beds", EMBO J, 37, pp.e98271~ (2018)
62. Yang Y, "VE-Cadherin is required for lymphatic valve formation and maintenance", Cell Rep, 28, pp.2397~2412 (2019)
63. Au AC, "Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans", Am J Hum Genet, 87, pp.436~444 (2010)
64. Liu X, "PTPN14 interacts with and negatively regulates the oncogenic function of YAP", Oncogene, 32, pp.1266~1273 (2013)
65. Wilson KE, "PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function", J Biol Chem, 289, pp.23693~23700 (2014)
66. Wang W, "PTPN14 is required for the density-dependent control of YAP1", Genes Dev, 26, pp.1959~1971 (2012)
67. Dupont S, "Role of YAP", TAZ in mechanotransduction, 2011, pp.474, 179~183
68. Panciera T, "Mechanobiology of YAP and TAZ in physiology and disease", Nat Rev Mol Cell Biol, 18, pp.758~770 (2017)
69. Wang KC, "Flow-dependent YAP", TAZ activities regulate endothelial phenotypes and atherosclerosis, 2016, pp.113, 11525~11530
70. Wang L, "Integrin-YAP", TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow, 2016, pp.540, 579~582
71. Nakajima H, "Flow-dependent endothelial YAP regulation contributes to vessel maintenance", Dev Cell, 40, pp.523~536 (2017)
72. Nakajima H, "Flow patterndependent endothelial cell responses through transcriptional regulation", Cell Cycle, 16, pp.1893~1901 (2017)
73. Choi D, "Laminar flow downregulates Notch activity to promote lymphatic sprouting", J Clin Invest, 127, pp.1225~1240 (2017)
74. Geng X, "S1PR1regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling", JCI Insight, 5, pp.e137652~ (2020)
75. Liu Z, "Induction of store-operated calcium entry(SOCE). suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP", TAZ, 2019, pp.38, 120~139
76. Choi D, "Piezo1 incorporates mechanical force signals into the genetic program that governs lymphatic valve development and maintenance", JCI Insight, 4, pp.e125068~ (2019)
77. Nonomura K, "Mechanically activated ion channel PIEZO1 is required for lymphatic valve formation", Proc Natl Acad Sci U S A, 115, pp.12817~12822 (2018)
78. Pathak MM, "Stretchactivated ion channel Piezo1 directs lineage choice in human neural stem cells", Proc Natl Acad Sci U S A, 111, pp.16148~16153 (2014)
79. Zhou T, "Piezo1", 2 mediate mechanotransduction essential for bone formation through concerted activation of NFAT-YAP1-β-catenin, 2020, pp.9, e52779~
80. Wang L, "Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk", Nat Commun, 11, pp.282~ (2020)
81. Sun Z, "Integrin-mediated mechanotransduction", J Cell Biol, 215, pp.445~456 (2016)
82. Rausch V, "The Hippo pathway, YAP", TAZ, and the plasma membrane, 2020, pp.30, 32~48
83. Frye M, "Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program", Nat Commun, 9, pp.1511~ (2018)
84. Aragona M, "A mechanical checkpoint controls multicellular growth through YAP", TAZ regulation by actin-processing factors, 2013, pp.154, 1047~1059
85. Planas-Paz L, "Mechanoinduction of lymph vessel expansion", EMBO J, 31, pp.788~804 (2012)
86. Yu FX, "Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling", Cell, 150, pp.780~791 (2012)
87. Hoopes SL, "Characteristics of multi-organ lymphangiectasia resulting from temporal deletion of calcitonin receptor-like receptor in adult mice", PLoS One, 7, pp.e45261~ (2008)
88. Lee SJ, "LPA1 is essential for lymphatic vessel development in zebrafish", FASEB J, 22, pp.3706~3715 (2008)
89. Sumida H, "LPA4regulates blood and lymphatic vessel formation during mouse embryogenesis", Blood, 116, pp.5060~5070 (2010)
90. Lin CI, "Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells", Cell Mol Life Sci, 65, pp.2740~2751 (2008)
91. Yoon CM, "Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1", Gi, Ca2+ signaling pathways, pp.Blood, 2008[DOI]
92. Kim W, "Wnt", beta-catenin signalling : from plasma membrane to nucleus, 2013, pp.450, 9~21
93. Nusse R, "Wnt", beta-catenin signaling, disease, and emerging therapeutic modalities, 2017, pp.169, 985~999
94. Clevers H, "Wnt", beta-catenin signaling and disease, 2012, pp.149, 1192~1205
95. 김민성, "Cross-talk between Wnt", β-catenin and Hippo signaling pathways: a brief review, 2014, pp.47(10), 540~545[DOI]
96. Azzolin L, "Role of TAZ as mediator of Wnt signaling", Cell, 151, pp.1443~1456 (2012)
97. Azzolin L, "YAP", TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response, 2014, pp.158, 157~170
98. Park HW, "Alternative Wnt signaling activates YAP", TAZ, 2015, pp.162, 780~794
99. Lutze G, "Non-canonical WNT-signaling controls differentiation of lymphatics and extension lymphangiogenesis via RAC and JNK signaling", Sci Rep, 9, pp.4739~ (2019)
100. Cha B, "Complementary Wnt sources regulate lymphatic vascular development via PROX1-dependent Wnt", β-catenin signaling, 2018, pp.25, 571~584
101. Majumder S, "Targeting Notch in oncology : the path forward", Nat Rev Drug Discov, 20, pp.125~144 (2021)
102. Bray SJ, "Notch signalling in context", Nat Rev Mol Cell Biol, 17, pp.722~735 (2016)
103. Tschaharganeh DF, "Yesassociated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma", Gastroenterology, 144, pp.1530~1542 (2013)
104. Kim W, "Hippo signaling interactions with Wnt", β-catenin and Notch signaling repress liver tumorigenesis, 2017, pp.127, 137~152
105. Kang J, "An exquisite crosscontrol mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells", Blood, 116, pp.140~150 (2010)
106. Fatima A, "Murine Notch1is required for lymphatic vascular morphogenesis during development", Dev Dyn, 243, pp.957~964 (2014)
107. Niessen K, "The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development", Blood, 118, pp.1989~1997 (2011)
108. Srinivasan RS, "Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature", Genes Dev, 21, pp.2422~2432 (2007)
109. Wigle JT, "Prox1 function is required for the development of the murine lymphatic system", Cell, 98, pp.769~778 (1999)
110. Yaniv K, "Live imaging of lymphatic development in the zebrafish", Nat Med, 12, pp.711~716 (2006)
111. Srinivasan RS, "The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells", Genes Dev, 24, pp.696~707 (2010)
112. Hong YK, "Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate", Dev Dyn, 225, pp.351~357 (2002)
113. François M, "Sox18induces development of the lymphatic vasculature in mice", Nature, 456, pp.643~647 (2008)
114. Srinivasan RS, "The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors", Genes Dev, 28, pp.2175~2187 (2014)
115. Koltowska K, "Vegfc regulates bipotential precursor division and Prox1 expression to promote lymphatic identity in zebrafish", Cell Rep, 13, pp.1828~1841 (2015)
116. Yang Y, "Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos", Blood, 120, pp.2340~2348 (2012)
117. Hägerling R, "A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy", EMBO J, 32, pp.629~644 (2013)
118. Karkkainen MJ, "Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins", Nat Immunol, 5, pp.74~80 (2004)
119. Semo J, "Development of the lymphatic system : new questions and paradigms", Development, 143, pp.924~935 (2016)
120. Chen H, "Molecular and cellular mechanisms of lymphatic vascular maturation", Microvasc Res, 96, pp.16~22 (2014)
121. Martinez-Corral I, "Nonvenous origin of dermal lymphatic vasculature", Circ Res, 116, pp.1649~1654 (2015)
122. James JM, "TGFβ signaling is required for sprouting lymphangiogenesis during lymphatic network development in the skin", Development, 140, pp.3903~3914 (2013)
123. Petrova TV, "Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis", Nat Med, 10, pp.974~981 (2004)
124. Yuan L, "Abnormal lymphatic vessel development in neuropilin 2 mutant mice", Development, 129, pp.4797~4806 (2002)
125. Mahamud MR, "GATA2controls lymphatic endothelial cell junctional integrity and lymphovenous valve morphogenesis through miR-126", Development, 146, pp.dev184218~ (2019)
126. Srinivasan RS, "Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves", Genes Dev, 25, pp.2187~2197 (2011)
127. Tammela T, "Lymphangiogenesis : Molecular mechanisms and future promise", Cell, 140, pp.460~476 (2010)
128. Geng X, "Multiple mouse models of primary lymphedema exhibit distinct defects in lymphovenous valve development", Dev Biol, 409, pp.218~233 (2016)
129. Geng X, "Intraluminal valves : development, function and disease", Dis Model Mech, 10, pp.1273~1287 (2017)
130. Norrmén C, "FOXC2controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1", J Cell Biol, 185, pp.439~457 (2009)
131. Kazenwadel J, "GATA2 is required for lymphatic vessel valve development and maintenance", J Clin Invest, 125, pp.2979~2994 (2015)
132. Danussi C, "EMILIN1", α9β1 integrin interaction is crucial in lymphatic valve formation and maintenance, 2013, pp.33, 4381~4394
133. Bazigou E, "Primary and secondary lymphatic valve development : molecular, functional and mechanical insights", Microvasc Res, 96, pp.38~45 (2014)
134. Roth Flach RJ, "Endothelial mitogen-activated protein kinase kinase kinase kinase 4 is critical for lymphatic vascular development and function", Mol Cell Biol, 36, pp.1740~1749 (2016)

관련 논문AI추천